KRAS and neoplasm: In patients without tissue profiling EGFR ex19del, EGFR L858R and KRAS G12/G13 mutations were detected by ddPCR in two, one and ten patients, respectively, corresponding to 7.1% of all patients without NGS of tumour tissue.